Quanterix Corp

For the period ended Sep 30, 2025. Filed Nov 10, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 10, 2025

QTRX$3.38+16.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

Consolidated Balance Sheets Consolidated Statements of Operations Consolidated Statements of Comprehensive Loss Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures

PART II — OTHER INFORMATION

Item 1. Legal Proceedings Item 1A. Risk Factors

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities (no text here)

Item 3. Defaults Upon Senior Securities (no text here)

Item 4. Mine Safety Disclosures (no text here)

Item 5. Other Information Item 6. Exhibits Signatures

Consolidated Statements of Operations

(amounts in thousands, except per share data, unaudited)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Revenues:
Product revenue	$26,151	$19,694	$63,723	$59,251
Service and other revenue	13,953	13,845	29,806	39,323
Collaboration and license revenue	46	1,872	1,348	2,756
Grant revenue	83	402	165	930
Total revenues	40,233	35,813	95,042	102,260
Costs of goods sold and services:
Cost of product revenue	15,379	10,554	34,438	25,461
Cost of service and other revenue	7,648	5,106	15,683	15,864
Total costs of goods sold and services	23,027	15,660	50,121	41,325
Gross profit	17,206	20,153	44,921	60,935
Operating expenses:
Research and development	8,009	8,104	27,126	23,015
Selling, general and administrative	39,062	22,908	102,872	73,027
Other lease costs	286	889	870	2,740
Impairment and restructuring costs	7,174	—	14,844	—
Total operating expenses	54,531	31,901	145,712	98,782
Loss from operations	(37,325)	(11,748)	(100,791)	(37,847)
Other income (expense):
Interest income	1,448	3,535	7,408	11,165
Change in fair value of contingent liabilities	58	—	3,952	—
Other income (expense), net	(178)	5	(68)	221
Loss before income taxes	(35,997)	(8,208)	(89,499)	(26,461)
Income tax benefit (expense)	2,480	(145)	5,466	(442)
Net loss	$(33,517)	$(8,353)	$(84,033)	$(26,903)
Net loss per common share, basic and diluted	$(0.73)	$(0.22)	$(2.04)	$(0.70)
Weighted-average common shares outstanding, basic and diluted	46,060	38,449	41,243	38,305

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.